Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Intraepithelial Lesions 1HIV Seropositivity 1

Interventions

VGX-3100 4Light Coagulation 3Watchful Waiting 2Polymerase Chain Reaction 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2Solutions 1Radiofrequency Ablation 1Observation 1Mindfulness-Based Stress Reduction 1Laser Therapy 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Histological Techniques 1Gene Expression Profiling 1Folic Acid 1Electroporation Therapies 1Data Collection 1DNA Methylation 1Blue Light 1Biopsy 1Aminolevulinic Acid 15-aminolaevulinic acid-n-pentylester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Squamous Intraepithelial Lesions × Electroporation Therapies × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡